checkAd

     150  0 Kommentare MustGrow Biologics and Univar Canada Ltd. Subsidiary NexusBioAg Announce Collaborative Field Trials Program in Canada


    DGAP-Media / 29.04.2021 / 13:07

    - Field Trials to commence for MustGrow's mustard-derived soil biopesticide in Canada for treatment of Clubroot disease in Canola and Aphanomyces disease in Pulse Crops.

    - MustGrow's organic biopesticide is plant-based, harnessing the mustard seed's natural defense mechanism to control diseases, insect pests, and weeds.


    SASKATOON, Saskatchewan, Canada, April 29, 2021 - MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) ("MustGrow") and Univar Canada Ltd.'s NexusBioAg ("NexusBioAg"), a division of Univar Solutions Inc., are pleased to announce a collaborative field trial program in Canada (the "Field Trials"). NexusBioAg will conduct the Field Trials of MustGrow's mustard-derived biopesticide, TerraMG, (the "Product", or "Products") for treatment of Clubroot and Aphanomyces diseases in Canola and Pulse Crops, respectively.

    MustGrow's remarkably safe and effective organic biopesticide is plant-based - harnessing the mustard seed's natural defense mechanism to control diseases, insect pests, and weeds.

    Utilizing its vast technical and commercial expertise, NexusBioAg will be responsible for conducting the Field Trials. MustGrow will supply NexusBioAg with the Products for testing along with scientific support.

    "We are very excited to partner with an organization like NexusBioAg. Their expertise in both the technical and commercial areas will be advantageous in accelerating the development and potential commercialization of TerraMG for use in Canada on canola and pulse crops. The NexusBioAg team has tremendous knowledge of Canadian agriculture as well as sustainable farming solutions." MustGrow COO Colin Bletsky remarked.

    Daniel Samphir, NexusBioAg Marketing Manager added, "MustGrow's R&D team has developed a sustainable farming solution to address the agronomic challenges of treating Clubroot and Aphanomyces. We are excited to add TerraMG to our field trial program to further demonstrate that TerraMG is complementary to the NexusBioAg portfolio."

    Clubroot Disease: Canola

    In August 2020, MustGrow reported control of Clubroot in greenhouse soil; of particular note: 96.1% disease control at 0.5 gal/acre application rate; and 98.5% disease control at 10 gal/acre application rate.

    Seite 1 von 4


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    MustGrow Biologics and Univar Canada Ltd. Subsidiary NexusBioAg Announce Collaborative Field Trials Program in Canada DGAP-Media / 29.04.2021 / 13:07 - Field Trials to commence for MustGrow's mustard-derived soil biopesticide in Canada for treatment of Clubroot disease in Canola and Aphanomyces disease in Pulse Crops. - MustGrow's organic biopesticide is …